These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6803690)
1. The cell saver during cardiac surgery: does it save? Winton TL; Charrette EJ; Salerno TA Ann Thorac Surg; 1982 Apr; 33(4):379-81. PubMed ID: 6803690 [TBL] [Abstract][Full Text] [Related]
2. Blood conservation for myocardial revascularization. Is it cost effective? Breyer RH; Engelman RM; Rousou JA; Lemeshow S J Thorac Cardiovasc Surg; 1987 Apr; 93(4):512-22. PubMed ID: 3104693 [TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of cell salvage in routine cardiac surgery. Klein AA; Nashef SA; Sharples L; Bottrill F; Dyer M; Armstrong J; Vuylsteke A Anesth Analg; 2008 Nov; 107(5):1487-95. PubMed ID: 18931203 [TBL] [Abstract][Full Text] [Related]
4. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083 [TBL] [Abstract][Full Text] [Related]
5. The benefit of the Hemonetics cell saver apparatus during cardiac surgery. Hall RI; Schweiger IM; Finlayson DC Can J Anaesth; 1990 Sep; 37(6):618-23. PubMed ID: 2119900 [TBL] [Abstract][Full Text] [Related]
6. Routine use of autotransfusion following cardiac surgery: experience in 700 patients. Schaff HV; Hauer J; Gardner TJ; Donahoo JS; Watkins L; Gott VL; Brawley RK Ann Thorac Surg; 1979 Jun; 27(6):493-9. PubMed ID: 313198 [TBL] [Abstract][Full Text] [Related]
7. Use of Haemonetics Cell Saver for autotransfusion in cardiovascular surgery. Ottesen S; Frøysaker T Scand J Thorac Cardiovasc Surg; 1982; 16(3):263-8. PubMed ID: 6984982 [TBL] [Abstract][Full Text] [Related]
8. Should the Cell Saver Autotransfusion Device be used routinely in all infrarenal abdominal aortic bypass operations? Kelley-Patteson C; Ammar AD; Kelley H J Vasc Surg; 1993 Aug; 18(2):261-5. PubMed ID: 8350435 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Bell K; Stott K; Sinclair CJ; Walker WS; Gillon J Transfus Med; 1992 Dec; 2(4):295-300. PubMed ID: 1285042 [TBL] [Abstract][Full Text] [Related]
10. Should the cell saver autotransfusion system be routinely used in elective aortic surgery? Serrano FJ; Moñux G; Aroca M Ann Vasc Surg; 2000 Nov; 14(6):663-8. PubMed ID: 11128464 [TBL] [Abstract][Full Text] [Related]
11. Complement activation and use of a cell saver in cardiopulmonary bypass. Deleuze P; Intrator L; Liou A; Contremoulins I; Cachera JP; Loisance DY ASAIO Trans; 1990; 36(3):M179-81. PubMed ID: 2252652 [TBL] [Abstract][Full Text] [Related]
12. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device. Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140 [TBL] [Abstract][Full Text] [Related]
13. [Reduction of the amount of perioperative blood transfusion by autotransfusion techniques in valvular heart surgery]. Nishihama M; Takigawa A; Soga K; Hirose Y Masui; 1993 Mar; 42(3):406-11. PubMed ID: 8468785 [TBL] [Abstract][Full Text] [Related]